Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Limping child: ages 0-5 years.

BIBLIOGRAPHIC SOURCE(S)

  • Fordham L, Gunderman R, Blatt ER, Bulas D, Coley BD, Podberesky DJ, Prince JS, Tosi L, Expert Panel on Pediatric Imaging. Limping child--ages 0-5 years. [online publication]. Reston (VA): American College of Radiology (ACR); 2007. 5 p. [59 references]

GUIDELINE STATUS

This is the current release of the guideline.

The appropriateness criteria are reviewed annually and updated by the panels as needed, depending on introduction of new and highly significant scientific evidence.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

ACR Appropriateness Criteria®

Clinical Condition: Limping Child--Ages 0-5 Years

Variant 1: Nonfocal clinical exam.

Radiologic Procedure Rating Comments RRL*
X-ray pelvis and lower extremity 8 Pelvis, femur (including knee), lower leg and foot are all imaged. Min
NUC bone scan 3-phase lower extremity 6 Follow-up study when limping persists and radiographs negative. Med
MRI pelvis and lower extremity 6 Follow-up study as needed. See comments regarding contrast in text under "Anticipated Expectations." None
US hip 5 Follow-up study as needed. None
X-ray spine 3   Low
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 2: Focal clinical exam (not septic arthritis).

Radiologic Procedure Rating Comments RRL*
X-ray area of interest 9 Consider imaging region above and below area of concern. NS
NUC bone scan 3-phase lower extremity 7 Follow-up study as needed. Med
MRI area of interest 7 Follow-up study as needed. Use contrast as clinically indicated. See comments regarding contrast in text under "Anticipated Expectations." None
US area of interest 3   None
CT area of interest 2   NS
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 3: Suspected septic arthritis.

Radiologic Procedure Rating Comments RRL*
X-ray area of interest 9   NS
US area of interest 8 Most useful at hip. None
NUC bone scan 3-phase lower extremity 7 Follow-up study as needed. Med
MRI area of interest 7 Follow-up study as needed. See comments regarding contrast in text under "Anticipated Expectations." None
CT area of interest 2   NS
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Summary of Literature Review

Limping is a common clinical problem in childhood, and it can be a diagnostic dilemma. Limping is a specific type of gait abnormality due to pain. Typically, one must consider processes from the spine to the toes as potential causes of a limp, which makes the list of possibilities quite long. Children frequently are unable to accurately localize the source of pain, and when the pain is localized it may actually be referred from above or below the painful region, adding to the difficulty in diagnosis.

The conditions to be considered will depend in part on the patient's age. Common conditions leading to a limping child include soft-tissue or bone injuries; infection of the bone, soft tissues or joints; and neuromuscular, congenital, developmental, ischemic, and neoplastic processes.

In one prospective study of 243 children under 14 years of age presenting with a limp, the most common diagnosis was transient synovitis. There are many less common causes as well. The patient may have a self-limited problem, but could also have a traumatic, inflammatory, or neoplastic condition requiring diagnosis and treatment. Some entities such as septic arthritis require rapid diagnosis to prevent or limit adverse outcomes. Others can be diagnosed in a more temperate fashion, based on clinical course. A detailed history and complete physical exam are essential in assessing a child with a limp. In many cases, no imaging is required, while others may require extensive imaging evaluation.

No large prospective studies have been performed to evaluate imaging algorithms in the child presenting with a limp. However, studies have examined individual diagnoses that lead to this presentation. Even in children with trauma, there is discussion about the appropriate radiologic evaluation.

Plain-film radiography has been used extensively in evaluating the limping child. It allows for a rapid overview, and triage and is recommended in many imaging algorithms. Usually, radiographs of the entire lower extremity, including the feet, have been obtained due to the relatively high prevalence of occult fracture. However, studies by one group of investigators demonstrated that as many as 26% of lower-extremity radiographs in injured children could be avoided with only a 5% incidence of missed fractures if clinical criteria were used in selecting patients for radiography. Similarly, another group demonstrated that examination for gross deformity and pain on motion predicted lower-extremity fractures in the post-trauma setting, with 97% of children with fractures being correctly identified. In the limping child without a history of trauma, plain radiographs of the lower extremities are typically normal. Another group found that fracture was the cause of a limp in 20% of 500 preschoolers who presented with a limp, while another group found radiographic studies to be normal in 96% of patients presenting with limp, inability to bear weight, or frequent falling, and the few abnormalities identified were relatively insignificant. On the other hand, plain film is all that is required for detection of diagnoses such as slipped capital femoral epiphysis, permitting early surgical intervention.

Ultrasonographic evaluation has mainly been used in evaluating the irritable hip. Two groups of investigators found that ultrasound (US) was helpful as the primary imaging technique in transient synovitis, with radiography being unnecessary in uncomplicated cases. Another group found toxic synovitis to be the most common diagnosis in the child with a limp, and they routinely use US as the primary imaging modality, reserving plain film for cases where the US was negative. However, a false negative rate of 5% was reported in one study due to inadequate exams or very early scanning. Another group found similar findings, reserving radionuclide bone scans for those with positive findings on US. US guidance can also be useful in guiding joint aspiration to differentiate septic arthritis from toxic synovitis, particularly in the hip.

Aspiration is the gold standard in differentiating toxic synovitis from septic arthritis, but others suggest that not all effusions need to be aspirated. In a prospective study of 53 children who had undergone US-guided aspiration because of an irritable hip, one group of investigators found that fever, an elevated C-reactive protein level, an elevated erythrocyte sedimentation rate, lack of weight-bearing, and an elevated serum white-blood-cell count were predictors of septic arthritis. The probability of septic arthritis was estimated to be 98% when five predictors were present, 93% when four predictors were present, and 83% when three predictors were present. US can also detect alternate diagnoses such as osteomyelitis and Legg-Perthes disease.

Radionuclide bone scans have been shown to be efficacious in evaluating limping children younger than 5 years of age, particularly when the exam is nonfocal. One group of investigators studied patients without a history of infection, child abuse, malignancy, or radiographic abnormalities of the lower extremities and found that 30 out of 56 patients had abnormal bone scans. Another group studied a group of 50 patients who had no diagnosis after clinical, laboratory, and plain-films radiographic evaluation. They found that 54% of the patients had abnormal bone scans localized to a specific region. Bone scan also plays a role in diagnosis and prognosis in Legg-Calve-Perthes disease, where the scintigraphic finds may predict the severity of the disease progression. Fluorodeoxyglucose positron emission tomography (FDG-PET) imaging and leukocyte scintigraphy can be useful in chronic osteomyelitis, outperforming magnetic resonance imaging (MRI) and plain films in a study by another group.

Due to radiation concerns and the efficacy of other imaging modalities, the role of computed tomography is limited in the child with a limp. It can be useful in preoperative evaluation of known fracture and in identifying osteopenia in a small subgroup of children with negative MRI evaluation for stress fracture.

MRI is useful in a number of different conditions that lead to a limp in a child. It can detect many early stress fractures, detect early Legg-Perthes disease, and osteomyelitis. It may even help in differentiating toxic synovitis from septic arthritis, as bone marrow signal abnormalities are seen more commonly in septic arthritis. Whole-body MRI may also be helpful in children with multifocal lesions. MRI can also help in differentiating bone infarcts from osteomyelitis.

In summary, the evaluation of the child with a limp must start first with a detailed history and physical examination, including an analysis of gait. If the cause of limping is evident clinically (neuromuscular disease or minor trauma), further assessment may be unnecessary. If the patient's pain can be accurately localized clinically, appropriate radiographic views of the area should be obtained. However, if the source of the limp cannot be localized, a medical decision will first have to be made whether imaging assessment is initially required or if further clinical observation is appropriate. For patients who have persistent signs and symptoms, or a clinical assessment that points to the possibility of significant trauma, infection, or tumor as the cause of the problem, consideration should be given to performing additional plain films, US, MRI, or radionuclide bone scan.

Anticipated Exceptions

Nephrogenic systemic fibrosis (NSF, also known as nephrogenic fibrosing dermopathy) was first identified in 1997 and has recently generated substantial concern among radiologists, referring doctors and lay people. Until the last few years, gadolinium-based MR contrast agents were widely believed to be almost universally well tolerated, extremely safe and non-nephrotoxic, even when used in patients with impaired renal function. All available experience suggests that these agents remain generally very safe, but recently some patients with renal failure who have been exposed to gadolinium contrast agents (the percentage is unclear) have developed NSF, a syndrome that can be fatal. Further studies are necessary to determine what the exact relationships are between gadolinium-containing contrast agents, their specific components and stoichiometry, patient renal function and NSF. Current theory links the development of NSF to the administration of relatively high doses (e.g., >0.2 mM/kg) and to agents in which the gadolinium is least strongly chelated. The FDA has recently issued a "black box" warning concerning these contrast agents (http://www.fda.gov/cder/drug/InfoSheets/HCP/gcca_200705HCP.pdf).

This warning recommends that, until further information is available, gadolinium contrast agents should not be administered to patients with either acute or significant chronic kidney disease (estimated GFR <30 mL/min/1.73m2), recent liver or kidney transplant or hepato-renal syndrome, unless a risk-benefit assessment suggests that the benefit of administration in the particular patient clearly outweighs the potential risk(s).

Abbreviations

  • CT, computed tomography
  • Med, medium
  • Min, minimal
  • MRI, magnetic resonance imaging
  • NS, not specified
  • NUC, nuclear medicine
  • US, ultrasound

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The recommendations are based on analysis of the current literature and expert panel consensus.

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • Fordham L, Gunderman R, Blatt ER, Bulas D, Coley BD, Podberesky DJ, Prince JS, Tosi L, Expert Panel on Pediatric Imaging. Limping child--ages 0-5 years. [online publication]. Reston (VA): American College of Radiology (ACR); 2007. 5 p. [59 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

1995 (revised 2007)

GUIDELINE DEVELOPER(S)

American College of Radiology - Medical Specialty Society

SOURCE(S) OF FUNDING

The American College of Radiology (ACR) provided the funding and the resources for these ACR Appropriateness Criteria®.

GUIDELINE COMMITTEE

Committee on Appropriateness Criteria, Expert Panel on Pediatric Imaging

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Panel Members: Lynn Fordham, MD; Richard Gunderman, MD, PhD; Ellen R. Blatt, MD; Dorothy Bulas, MD; Brian D. Coley, MD; Daniel J. Podberesky, MD; Jeffrey Scott Prince, MD; Laura Tosi, MD

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

The appropriateness criteria are reviewed annually and updated by the panels as needed, depending on introduction of new and highly significant scientific evidence.

GUIDELINE AVAILABILITY

Electronic copies: Available in Portable Document Format (PDF) from the American College of Radiology (ACR) Web site.

ACR Appropriateness Criteria® Anytime, Anywhere™ (PDA application). Available from the ACR Web site.

Print copies: Available from the American College of Radiology, 1891 Preston White Drive, Reston, VA 20191. Telephone: (703) 648-8900.

AVAILABILITY OF COMPANION DOCUMENTS

PATIENT RESOURCES

None available

NGC STATUS

This NGC summary was completed by ECRI Institute on December 20, 2007.

COPYRIGHT STATEMENT

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo